• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过气相色谱-质谱联用技术对帕金森病脑组织中多巴胺代谢物的确认。

Confirmation of a dopamine metabolite in parkinsonian brain tissue by gas chromatography-mass spectrometry.

作者信息

Mattammal M B, Chung H D, Strong R, Hsu F F

机构信息

Geriatric Research, Education and Clinical Center, VA Medical Center, St. Louis, MO 63104.

出版信息

J Chromatogr. 1993 May 5;614(2):205-12. doi: 10.1016/0378-4347(93)80310-z.

DOI:10.1016/0378-4347(93)80310-z
PMID:8314932
Abstract

Gas chromatography-mass spectrometry was used to identify a dopamine metabolite isolated from the substantia nigra of parkinsonian brain tissue. Incubation of dopamine with monoamine oxidase B gave the same product which was identified as 3,4-dihydroxyphenylacetaldehyde. The structure of the compound was established by chemical synthesis, metastable ion measurement and high-resolution mass spectrometry.

摘要

气相色谱 - 质谱联用技术被用于鉴定从帕金森病脑组织黑质中分离出的一种多巴胺代谢产物。多巴胺与单胺氧化酶B孵育产生了相同的产物,该产物被鉴定为3,4 - 二羟基苯乙醛。通过化学合成、亚稳离子测量和高分辨率质谱确定了该化合物的结构。

相似文献

1
Confirmation of a dopamine metabolite in parkinsonian brain tissue by gas chromatography-mass spectrometry.通过气相色谱-质谱联用技术对帕金森病脑组织中多巴胺代谢物的确认。
J Chromatogr. 1993 May 5;614(2):205-12. doi: 10.1016/0378-4347(93)80310-z.
2
Quantitation of 3,4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde, the monoamine oxidase metabolites of dopamine and noradrenaline, in human tissues by microcolumn high-performance liquid chromatography.采用微柱高效液相色谱法对人体组织中多巴胺和去甲肾上腺素的单胺氧化酶代谢产物3,4-二羟基苯乙醛和3,4-二羟基苯乙醇醛进行定量分析。
Anal Biochem. 1999 Aug 15;273(1):111-6. doi: 10.1006/abio.1999.4196.
3
Catechols in post-mortem brain of patients with Parkinson disease.帕金森病患者死后大脑中的儿茶酚胺。
Eur J Neurol. 2011 May;18(5):703-10. doi: 10.1111/j.1468-1331.2010.03246.x. Epub 2010 Nov 12.
4
3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.3,4-二羟基苯乙醛是体内有毒的多巴胺代谢产物:对帕金森病发病机制的影响。
Brain Res. 2003 Nov 7;989(2):205-13. doi: 10.1016/s0006-8993(03)03354-7.
5
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing -Synuclein.3,4-二羟基苯乙醛比多巴胺更有效地使α-突触核蛋白低聚和醌化。
J Pharmacol Exp Ther. 2020 Feb;372(2):157-165. doi: 10.1124/jpet.119.262246. Epub 2019 Nov 19.
6
Effect of monoamine oxidase gene knockout on dopamine metabolism in mouse brain structures.单胺氧化酶基因敲除对小鼠脑结构中多巴胺代谢的影响。
Bull Exp Biol Med. 2004 Apr;137(4):382-4. doi: 10.1023/b:bebm.0000035137.97552.ab.
7
3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis.3,4-二羟基苯乙醛与过氧化氢生成羟自由基:在帕金森病发病机制中的可能作用
Brain Res Mol Brain Res. 2001 Sep 10;93(1):1-7. doi: 10.1016/s0169-328x(01)00120-6.
8
Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.α-突触核蛋白与多巴胺代谢产物在帕金森病发病机制中的相互作用:黑质选择性易损性的实例
Acta Neuropathol. 2006 Aug;112(2):115-26. doi: 10.1007/s00401-006-0096-2. Epub 2006 Jun 22.
9
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.选择性多巴胺能易损性:3,4-二羟基苯乙醛靶向线粒体。
Free Radic Biol Med. 2001 Apr 15;30(8):924-31. doi: 10.1016/s0891-5849(01)00484-1.
10
[Reactive oxygen species and 3,4-dihydroxyphenylacetaldehyde in pathogenesis of Parkinson disease].[活性氧与3,4-二羟基苯乙醛在帕金森病发病机制中的作用]
Przegl Lek. 2011;68(8):486-7.

引用本文的文献

1
Not 'Inactive' After All: Cardiotoxic Mechanisms of Catecholamine Metabolism by Monoamine Oxidase.并非“无活性”:单胺氧化酶对儿茶酚胺代谢的心脏毒性机制
Cardiovasc Toxicol. 2025 Jun 10. doi: 10.1007/s12012-025-10021-7.
2
Decoding crosstalk between neurotransmitters and α-synuclein in Parkinson's disease: pathogenesis and therapeutic implications.解读帕金森病中神经递质与α-突触核蛋白之间的串扰:发病机制及治疗意义
Ther Adv Neurol Disord. 2025 Jun 5;18:17562864251339895. doi: 10.1177/17562864251339895. eCollection 2025.
3
CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson's disease models.
CCL21-CCR7阻断可预防帕金森病模型中的神经炎症和神经变性。
J Neuroinflammation. 2025 Feb 2;22(1):31. doi: 10.1186/s12974-024-03318-x.
4
Impaired aldehyde detoxification exacerbates motor deficits in an alpha-synuclein mouse model of Parkinson's disease.α-突触核蛋白帕金森病小鼠模型中醛类解毒功能受损加剧运动缺陷。
Brain Behav. 2023 Sep;13(9):e3150. doi: 10.1002/brb3.3150. Epub 2023 Jul 14.
5
Modeling the Progression of Cardiac Catecholamine Deficiency in Lewy Body Diseases.路易体病中心脏儿茶酚胺缺乏进展的建模
J Am Heart Assoc. 2022 Jun 7;11(11):e024411. doi: 10.1161/JAHA.121.024411. Epub 2022 May 27.
6
The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.儿茶酚醛假说在儿茶酚胺能神经元变性发病机制中的作用:已知与未知。
Int J Mol Sci. 2021 Jun 1;22(11):5999. doi: 10.3390/ijms22115999.
7
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.儿茶酚胺自毒性。对帕金森病及相关疾病药理学和治疗学的影响。
Pharmacol Ther. 2014 Dec;144(3):268-82. doi: 10.1016/j.pharmthera.2014.06.006. Epub 2014 Jun 16.
8
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.缺乏细胞质和线粒体醛脱氢酶的小鼠的神经退行性变和运动功能障碍:对帕金森病的影响。
PLoS One. 2012;7(2):e31522. doi: 10.1371/journal.pone.0031522. Epub 2012 Feb 22.
9
From L-dopa to dihydroxyphenylacetaldehyde: a toxic biochemical pathway plays a vital physiological function in insects.从左旋多巴到二羟苯乙酸醛:有毒的生化途径在昆虫中起着至关重要的生理功能。
PLoS One. 2011 Jan 24;6(1):e16124. doi: 10.1371/journal.pone.0016124.
10
The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.DOPAL 的神经毒性:其在帕金森病发病机制中的作用的行为学和体视学证据。
PLoS One. 2010 Dec 13;5(12):e15251. doi: 10.1371/journal.pone.0015251.